[go: up one dir, main page]

GB9111885D0 - Nerve growth factor for use in the prevention and treatment of viral infections - Google Patents

Nerve growth factor for use in the prevention and treatment of viral infections

Info

Publication number
GB9111885D0
GB9111885D0 GB919111885A GB9111885A GB9111885D0 GB 9111885 D0 GB9111885 D0 GB 9111885D0 GB 919111885 A GB919111885 A GB 919111885A GB 9111885 A GB9111885 A GB 9111885A GB 9111885 D0 GB9111885 D0 GB 9111885D0
Authority
GB
United Kingdom
Prior art keywords
prevention
treatment
growth factor
viral infections
nerve growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919111885A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Priority to GB919111885A priority Critical patent/GB9111885D0/en
Publication of GB9111885D0 publication Critical patent/GB9111885D0/en
Priority to EP92909695A priority patent/EP0587590A1/en
Priority to JP4509159A priority patent/JPH06507397A/en
Priority to PCT/EP1992/000998 priority patent/WO1992021362A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB919111885A 1991-06-03 1991-06-03 Nerve growth factor for use in the prevention and treatment of viral infections Pending GB9111885D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB919111885A GB9111885D0 (en) 1991-06-03 1991-06-03 Nerve growth factor for use in the prevention and treatment of viral infections
EP92909695A EP0587590A1 (en) 1991-06-03 1992-05-07 Nerve growth factor for use in the prevention and treatment of viral infections
JP4509159A JPH06507397A (en) 1991-06-03 1992-05-07 Nerve growth factor used to prevent and treat viral infections
PCT/EP1992/000998 WO1992021362A1 (en) 1991-06-03 1992-05-07 Nerve growth factor for use in the prevention and treatment of viral infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111885A GB9111885D0 (en) 1991-06-03 1991-06-03 Nerve growth factor for use in the prevention and treatment of viral infections

Publications (1)

Publication Number Publication Date
GB9111885D0 true GB9111885D0 (en) 1991-07-24

Family

ID=10695991

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919111885A Pending GB9111885D0 (en) 1991-06-03 1991-06-03 Nerve growth factor for use in the prevention and treatment of viral infections

Country Status (4)

Country Link
EP (1) EP0587590A1 (en)
JP (1) JPH06507397A (en)
GB (1) GB9111885D0 (en)
WO (1) WO1992021362A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103572D0 (en) * 1991-11-29 1991-11-29 Astra Ab ORGANIC SALTS OF N, N'-DIACETYL CYSTINE
US5461029A (en) * 1992-04-24 1995-10-24 American Cyanamid Company Method of treating herpes viral infections using HBNF and MK proteins
DE10219545A1 (en) * 2002-04-26 2003-11-06 Lang Florian Regulation of apoptosis
CN111000984A (en) * 2019-11-16 2020-04-14 祁展楷 Application of snake nerve growth factor and snake nerve growth factor precursor in treating senile dementia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7518987A (en) * 1986-06-05 1988-01-11 Genetics Institute Inc. A novel protein, neuroleukin
IT1219874B (en) * 1988-03-18 1990-05-24 Fidia Farmaceutici USE OF THE HUMAN NERVE GROWTH FACTOR AND ITS PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
WO1992021362A1 (en) 1992-12-10
EP0587590A1 (en) 1994-03-23
JPH06507397A (en) 1994-08-25

Similar Documents

Publication Publication Date Title
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
AU1577792A (en) Implantation tissue and treatment and use methods
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
PL297849A1 (en) Vaccine against and method of treating the patients infectedwith hiv virus
GB9223552D0 (en) Improvements in or relating to the treatment of effluents
EP0499467A3 (en) Use of quinones in the treatment of cancer or aids
HU9202095D0 (en) Therapy and vaccine against aids
EP0382551A3 (en) Prevention and treatment of herpes virus infections
GB9111885D0 (en) Nerve growth factor for use in the prevention and treatment of viral infections
HU9302183D0 (en) Medical preparatives for preventing and treating osteoporises after menopausa
EP0496148A3 (en) Improvements in the treatment of ashes
AU4812393A (en) Use of rapamycin in the treatment of aids
ZA9010337B (en) Fibroblast growth factor for use in the prevention and treatment of viral infections
AU4319393A (en) Use of indolocarbazols in aids treatment
ZA928198B (en) Substituted azaspiranes for use in the treatment of hyperlipidemia
SG47098A1 (en) Diamines in the treatment of arrhythmia
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
EP0452941A3 (en) Use of isomonools in the treatment and prophylaxis of cancer
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis
NZ314730A (en) Use of dideoxycytosine derivatives in the treatment of viral infection
NZ233973A (en) Treatment of viral and/or bacterial infections
IL101630A0 (en) Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
LV10385B (en) Use of quinons in the treatment of cancer or aids
IL103488A0 (en) Polychlorodipyrido-imidazolium compounds and their use in the preparation of pentachloropyridine
EG20171A (en) Treatment of conditions and disease